4//SEC Filing
REXAHN PHARMACEUTICALS, INC. 4
Accession 0001140361-15-002937
$IRDCIK 0001228627operating
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 6:45 PM ET
Size
5.5 KB
Accession
0001140361-15-002937
Insider Transaction Report
Form 4
Suzdak Peter David
Chief Executive Officer
Transactions
- Award
Stock Option (right to purchase)
2015-01-23+1,100,000→ 1,100,000 totalExercise: $0.71Exp: 2025-01-23→ Common Stock (1,100,000 underlying)
Footnotes (1)
- [F1]Options will vest and be exercisable based on the following schedule: 275,000 on January 23, 2016, 275,000 on January 23, 2017, 275,000 on January 23, 2018, and 275,000 on January 23, 2019.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001228627
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 6:45 PM ET
- Size
- 5.5 KB